Search research articles
Contact Us
Filters
Showing results (101-110 of 706) with videos related to
Page
of 71
Sort By:
Expert Opinion on Pharmacotherapy
|
January 17, 2014
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
Amirhossein Sahebkar, Gerard T Chew, Gerald F Watts
Nature Clinical Practice. Cardiovascular Medicine
|
June 28, 2007
Familial hypercholesterolemia: a missed opportunity in preventive medicine
Gerald F Watts, Barry Lewis, David R Sullivan
Journal of Internal Medicine
|
April 4, 2020
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
Alpo Vuorio, Gerald F Watts, Petri T Kovanen
Atherosclerosis
|
May 3, 2015
Europe aspires to set the record straight on familial hypercholesterolaemia
Gerald F Watts, Jing Pang, Raul D Santos
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2025
Female Specific Risk of Pancreatitis in Severe Hypertriglyceridemia: Implications for Family Planning and New Guidelines
Mohamed Haseef, Dick C Chan, Gerald F Watts
International Journal of Clinical Pharmacy
|
May 25, 2012
Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?
Ines Krass, Adrian T Walker, Gerald F Watts
Progress in Lipid Research
|
August 2, 2014
Recent advances in pharmacotherapy for hypertriglyceridemia
Amirhossein Sahebkar, Gerard T Chew, Gerald F Watts
Journal of Atherosclerosis and Thrombosis
|
February 24, 2016
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
Jing Pang, Peter J Lansberg, Gerald F Watts
European Heart Journal
|
February 7, 2016
Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
Alpo Vuorio, Gerald F Watts, Petri T Kovanen
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 24, 2020
Lipoprotein (a) and diabetes mellitus: causes and consequences
Natalie C Ward, Shayimeera Vickneswaran, Gerald F Watts
Page
of 71
Search research articles
Search
Showing results (101-110 of 706) with videos related to
Sort By:
Page
of 71
Expert Opinion on Pharmacotherapy
|
January 17, 2014
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
Amirhossein Sahebkar, Gerard T Chew, Gerald F Watts
Nature Clinical Practice. Cardiovascular Medicine
|
June 28, 2007
Familial hypercholesterolemia: a missed opportunity in preventive medicine
Gerald F Watts, Barry Lewis, David R Sullivan
Journal of Internal Medicine
|
April 4, 2020
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
Alpo Vuorio, Gerald F Watts, Petri T Kovanen
Atherosclerosis
|
May 3, 2015
Europe aspires to set the record straight on familial hypercholesterolaemia
Gerald F Watts, Jing Pang, Raul D Santos
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2025
Female Specific Risk of Pancreatitis in Severe Hypertriglyceridemia: Implications for Family Planning and New Guidelines
Mohamed Haseef, Dick C Chan, Gerald F Watts
International Journal of Clinical Pharmacy
|
May 25, 2012
Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?
Ines Krass, Adrian T Walker, Gerald F Watts
Progress in Lipid Research
|
August 2, 2014
Recent advances in pharmacotherapy for hypertriglyceridemia
Amirhossein Sahebkar, Gerard T Chew, Gerald F Watts
Journal of Atherosclerosis and Thrombosis
|
February 24, 2016
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
Jing Pang, Peter J Lansberg, Gerald F Watts
European Heart Journal
|
February 7, 2016
Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
Alpo Vuorio, Gerald F Watts, Petri T Kovanen
Current Opinion in Endocrinology, Diabetes, and Obesity
|
November 24, 2020
Lipoprotein (a) and diabetes mellitus: causes and consequences
Natalie C Ward, Shayimeera Vickneswaran, Gerald F Watts
Page
of 71